LIXTE Biotechnology Holdings (NASDAQ: LIXT) Advances a Novel Approach to Enhancing Cancer Therapy23/01/2026
Half of workforce using unapproved AI tools, research showsBy News Team23/10/2024 A recent study reveals that half of the workforce utilises Shadow AI tools.These tools are not authorised by their companies, raising security concerns.Despite potential bans, 46%…
LIXTE Biotechnology Holdings (NASDAQ: LIXT) Advances a Novel Approach to Enhancing Cancer Therapy23/01/2026
